India Looks To Model New Central Drug Authority After U.S. FDA
This article was originally published in PharmAsia News
Executive Summary
NEW DELHI - With elections to parliament slated for next year, India's Congress Party-led government is expected to soon pass a slew of bills in the pharmaceutical sector, including that for a central drug authority
You may also be interested in...
India’s Drug Watchdog DCGI Speeds Up Regulatory Overhaul; Single Window Clearance to Precede Central Drug Authority
MUMBAI - India's drug regulatory body, the Drug Controller General of India, is set for a comprehensive overhaul of its regulatory and administrative functions
India’s Drug Watchdog DCGI Speeds Up Regulatory Overhaul; Single Window Clearance to Precede Central Drug Authority
MUMBAI - India's drug regulatory body, the Drug Controller General of India, is set for a comprehensive overhaul of its regulatory and administrative functions
Parliamentary Panel Not Yet Ready To Recommend India’s CDA Bill
NEW DELHI - A parliamentary committee examining the bills to set up a central drug authority in India is not yet set to give its recommendations, which would pave the way for the bills to be debated and passed in the parliament. The CDA bill has been approved by the country's Cabinet of Ministers and is currently with the parliamentary panel